About the Author:
Donald
Cairns obtained a Bachelor of Science
degree in pharmacy from the University of Strathclyde in 1980 and after a
pre-registration year spent in hospital pharmacy, he returned to Strathclyde to
undertake a PhD on the synthesis and properties of benzylimidazolines.
Following a year as a post-doctoral research fellow in the department of
pharmacy at Sunderland Polytechnic (now the University of Sunderland), Dr
Cairns moved to Leicester Polytechnic (now De Montfort University) where he
held a five-year lectureship in pharmacy.ln 1992 Dr Cairns was appointed senior
lecturer in medicinal chemistry in Sunderland School of Pharmacy and in
2003 moved to a post of Associate Head of the
School of Pharmacy at The Robert Gordon University in Aberdeen. ln 2006, he was
promoted to Professor of Pharmaceutical and Medicinal Chemistry at RGU and in
2010 was appointed Acting Head of the School of Pharmacy and Life Sciences.
Professor Cairns has served as external examiner
at Strathclyde, Liver-pool, Aberdeen and Belfast Schools of Pharmacy and has
authored over 70 peer reviewed research papers.
His research interests include the design and
synthesis of selective anti-cancer agents, the molecular modelling of drug-DNA
interactions and the design of prodrugs for the treatment of nephropathic
cystinosis.
Donald Cairns is a member of the General
Pharmaceutical Council, the Royal Pharmaceutical Society, the Association of
Pharmaceutical Scientists and in 2008 was made a Fellow of the Royal Society of
Chemistry. ln 2006 he was appointed to the British Pharmacopoeia Commission and
serves on an Expert Advisory Group of the Commission on Human Medicines.
To travel hopefully is a better thing than to
arrive, and the true success is to labour.
Robert Louis Stevenson, 1850-1894 |